Antigen News and Research

RSS

The 15th AACR cancer progress report highlights scientific advances

The American Association for Cancer Research (AACR) released the 15th edition of its annual Cancer Progress Report. A cornerstone of the AACR's educational and advocacy efforts, this comprehensive report provides the latest statistics on cancer incidence, mortality, and survivorship and highlights how federal investments in basic, translational, and clinical cancer research and cancer-related population sciences have led to impressive scientific advances that are improving health and saving lives.

17 Sep 2025

Novel biotechnical vector integrates viral and synthetic features for targeted cancer therapy

Gene therapy offers the possibility of addressing cancer at its molecular roots by targeting disease-causing genes rather than relying solely on surgery, chemotherapy, or radiotherapy.

16 Sep 2025

Study reveals how centenarians preserve youthful immune defenses

Researchers mapped immune cells from centenarians, their offspring, and younger controls across three cohorts using multi-omics single-cell profiling. They found that centenarians retain leaner helper pools but have enhanced cytotoxic and NK cell programs, along with reinforced NK–T communication networks.

15 Sep 2025

SwRI and UT San Antonio advance biosensor coating to streamline production of immunotherapies

Southwest Research Institute (SwRI) and The University of Texas at San Antonio (UT San Antonio) are advancing a smart biosensor coating to streamline the production of immunotherapies for cancer treatments.

15 Sep 2025

Primary care providers less likely to recommend PSA testing for Black men

Although Black men die of prostate cancer at twice the rate of the rest of U.S. males, this fact often is not known or considered during appointments with their primary-care clinicians to discuss a common screening test.

13 Sep 2025

UCLA team develops engineered antibodies to fight cytomegalovirus infection

A UCLA research team has found a new way to prompt the immune system to kill cells infected with cytomegalovirus (CMV), a life-threatening infection that is particularly deadly in immunocompromised people.

13 Sep 2025

A universal solution emerges: Anti-linker antibodies simplify CAR-T detection and development

CAR-T cell therapy has demonstrated remarkable success in treating hematologic malignancies and is now expanding into solid tumors.

From Sino Biological Inc. 13 Sep 2025

SLIT2 protein levels in the eye and blood linked to cognitive function

Neurocognitive impairments are classified by pathological changes with potential for destruction of neural tissue. One change known to occur in neurodegenerative disorders is an accumulation of proteins causing pathological damage.

11 Sep 2025

Johns Hopkins team develops urine-based test for prostate cancer detection

Researchers at the Johns Hopkins Kimmel Cancer Center, Johns Hopkins All Children's Hospital and four other institutions have devised a novel method to test for prostate cancer using biomarkers present in urine, funded in part by the National Institutes of Health.

9 Sep 2025

IFITM3 found to be critical regulator of immunotherapy sensitivity in small cell lung cancer

New research presented identifies interferon-induced transmembrane protein 3 (IFITM3) as a critical regulator of immunotherapy sensitivity in small cell lung cancer (SCLC), offering a promising new avenue for overcoming resistance to PD-1/PD-L1 checkpoint blockade.

9 Sep 2025

Concertgoers back detection dogs as practical COVID-19 screening tool in real-world trial

A feasibility study in Germany found that concertgoers strongly supported medical detection dogs for COVID-19 screening, with confidence rising after real-world use. The findings suggest canine testing could complement PCR and antigen tests, especially in large gatherings and high-traffic environments.

8 Sep 2025

Can an allergy spray help prevent COVID-19?

Researchers determine the efficacy and safety of azelastine nasal spray for preventing SARS-CoV-2 infection in healthy adults.

8 Sep 2025

Targeting metabolic reprogramming to overcome immune suppression in head and neck cancer

Head and neck cancer remains a major global health challenge, ranking among the six most common cancers worldwide and claiming hundreds of thousands of lives each year.

5 Sep 2025

Breakthrough technology enables faster and cheaper antibody analysis

Antibodies are the critical targeting agents of the immune system and the crux of immune therapy and vaccine development, but studying them is slow, expensive and labor-intensive.

4 Sep 2025

Logical Biological launches sister company, Logical Antigen, delivering customized antigen and protein purification for IVD market

Logical Biological, biospecimen and critical material experts, today announced the launch of a new sister company, Logical Antigen, focused on rapid and customized delivery of high-quality antigens and biologicals, for research and manufacturing of diagnostic products.

From Logical Biological 4 Sep 2025

Urine test identifies three biomarkers for accurate prostate cancer detection

2 Sep 2025

Prostate cancer rates rise as mortality decline slows in the United States

Today, the American Cancer Society (ACS) released Prostate Cancer Statistics, 2025, a report on current prostate cancer occurrence and outcomes in the United States.

2 Sep 2025

MicroRNA panels show promise for improving prostate cancer diagnosis

Prostate cancer is highly heterogeneous, ranging from slow-growing tumors to aggressive, life-threatening disease.

2 Sep 2025

KRISS develops ultra-sensitive platform to detect Alzheimer’s biomarkers in body fluids

The Korea Research Institute of Standards and Science (KRISS, President Lee Ho Seong) has developed a diagnostic platform that amplifies the unique optical signals of molecules by more than a hundred million times, enabling the precise detection and quantification of trace amounts of Alzheimer's disease biomarkers in body fluids.

1 Sep 2025

New off-the-shelf immunotherapy for metastatic kidney cancer could help improve outcomes

UCLA researchers have developed a new kind of immunotherapy that uses specially engineered immune cells equipped with built-in weapons to attack kidney cancer tumors and reprogram their protective environment - all without the need to customize treatment for each individual patient.

29 Aug 2025

Antigen News and Research

The 15th AACR cancer progress report highlights scientific advances

Novel biotechnical vector integrates viral and synthetic features for targeted cancer therapy

Study reveals how centenarians preserve youthful immune defenses

SwRI and UT San Antonio advance biosensor coating to streamline production of immunotherapies

Primary care providers less likely to recommend PSA testing for Black men

UCLA team develops engineered antibodies to fight cytomegalovirus infection

A universal solution emerges: Anti-linker antibodies simplify CAR-T detection and development

SLIT2 protein levels in the eye and blood linked to cognitive function

Johns Hopkins team develops urine-based test for prostate cancer detection

IFITM3 found to be critical regulator of immunotherapy sensitivity in small cell lung cancer

Concertgoers back detection dogs as practical COVID-19 screening tool in real-world trial

Can an allergy spray help prevent COVID-19?

Targeting metabolic reprogramming to overcome immune suppression in head and neck cancer

Breakthrough technology enables faster and cheaper antibody analysis

Logical Biological launches sister company, Logical Antigen, delivering customized antigen and protein purification for IVD market

Urine test identifies three biomarkers for accurate prostate cancer detection

Prostate cancer rates rise as mortality decline slows in the United States

MicroRNA panels show promise for improving prostate cancer diagnosis

KRISS develops ultra-sensitive platform to detect Alzheimer’s biomarkers in body fluids

New off-the-shelf immunotherapy for metastatic kidney cancer could help improve outcomes

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics